MedTech Milestone: Cornerstone Robotics Secures EU CE Mark for Sentire Surgical System

Hong Kong-based surgical robotics unicorn Cornerstone Robotics (CSR) has officially secured European Union CE Mark (MDR) certification for its flagship Sentire Endoscopic Surgical System. Announced early Monday morning, the rigorous regulatory milestone grants the high-end platform immediate commercial access to the European medical market.

The CE certification covers minimally invasive surgical procedures across four major clinical fields: General Surgery, Gynecology, Thoracic surgery, and Urology.

Clinical Validation: Real-World Testing in the UK

The regulatory approval follows extensive clinical investigations conducted in the United Kingdom. Since 2025, Cornerstone Robotics has partnered with the Portsmouth Hospitals University NHS Trust (PHU) to accumulate real-world data on the platform.

To date, the Sentire Surgical System has successfully executed complex soft-tissue surgeries in the UK, spanning upper and lower gastrointestinal tracks. CSR established a dedicated UK subsidiary last year to provide localized professional training, technical support, and clinical maintenance to European surgical teams ahead of this commercial rollout.

Financial Backing: $200 Million Expansion Engine

The milestone comes on the heels of a massive capital injection. In November 2025, Cornerstone Robotics closed an oversubscribed financing round, raising approximately $200 million USD from international investors specifically to scale its global commercial infrastructure.

The company maintains three global R&D hubs alongside a massive 30,000-square-meter manufacturing facility in China. With this new EU certification, the Sentire system is now officially cleared for market distribution across China, Singapore, and the European Union.

Anthony AI News Take: The MedTech Disruption

For years, the multi-billion-dollar global surgical robotics industry has been aggressively dominated by a few established Western monopolies like Intuitive Surgical's DaVinci system. What Cornerstone Robotics is achieving here is a textbook case of vertical integration disruption.

By developing their software, engineering, and high-speed imaging arrays completely in-house, CSR has managed to bypass heavy supply-chain costs. For readers of Anthony AI News tracking the robotics sector, this CE Mark validation proves that Asian medical hardware infrastructure has reached parity with strict Western regulatory metrics—setting up an intense market-share battle in global hospitals over the next twelve months.